A recent study investigated the correlation between mutant huntingtin (mHTT) and CSF and plasma NF-L levels in HD patients, revealing NF-L to be a clinically stronger marker than mHTT, even within the study’s limitations [33]. The gene discussed is NEFL; the disease is Huntington disease.